Displaying drugs 376 - 400 of 406 in total
Name | Weight | Structure | Desription | Categories |
---|---|---|---|---|
Thyroglobulin | 660.0 | For the treatment of hypothyroidism (deficiency in the production of thyroid hormone). | Globulins / Glycoproteins / Iodoproteins | |
Thyroid, porcine | Not Available | A naturally-occurring peptide hormone used for the replacement therapy for hypothyroidism of any etiology, treatment for euthyroid goiters, and management of thyroid cancers. | Agents used to treat hypothyroidism / Thyroid Products | |
Thyrotropin alfa | 22672.9 C975H1513N267O304S26 | A recombinant form of thyroid stimulating hormone used in diagnostic testing for thyroid cancer and alongside radioactive agents to destroy thyroid tissue. | Thyroid Products | |
Tilactase | 102000.0 | A beta-D-galactosidase use to treat lactose intolerance. | Enzyme Preparations | |
Tildrakizumab | 144400.0 C6426H9918N1698O2000S46 | An interleukin-23 antagonist used to treat moderate to severe plaque psoriasis. | Interleukin Inhibitors | |
Tirzepatide | 4810.52 C225H348N48O68 | A dual GIP and GLP-1 receptor agonist used for the treatment of type II diabetes in adults as an adjunct to diet and exercise. | Blood Glucose Lowering Agents / Incretins | |
Tislelizumab | Not Available | An IgG4 variant monoclonal antibody against PD-1 indicated for the treatment of unresectable, locally advanced or metastatic esophageal squamous cell carcinoma | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors | |
Tisotumab vedotin | 153000.0 | A tissue factor-directed antibody drug conjugate that is used to treat adults with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. | Antineoplastic Agents, Immunological | |
Tixagevimab | 149000.0 C6488H10034N1746O2038S50 | An extended half-life recombinant monoclonal IgG1κ antibody directed against the SARS-CoV-2 S protein for COVID-19 prophylaxis in individuals unable to undergo COVID-19 immunization. | Antiviral monoclonal antibodies | |
Tocilizumab | 148000.0 C6428H9976N1720O2018S42 | An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA). | Interleukin Inhibitors | |
Toripalimab | 150000.0 | A PD-1 blocking monoclonal antibody used for the treatment of metastatic and recurrent nasopharyngeal carcinomas. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Blood Proteins / Globulins / Immune Checkpoint Inhibitors / Immunoglobulins / Immunoproteins / Programmed Death Receptor-1 Blocking Antibody / Proteins / Serum Globulins | |
Tositumomab | 143859.7 C6416H9874N1688O1987S44 | A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. | Iodine (131I) Compounds | |
Tralokinumab | 147000.0 C6374H9822N1698O2014S44 | A monoclonal antibody directed against interleukin-13 which is used in the treatment of moderate-to-severe atopic dermatitis in patients requiring systemic therapy. | Agents for Dermatitis, Excluding Corticosteroids | |
Trastuzumab | 145531.5 C6470H10012N1726O2013S42 | A monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. | Antibodies, Monoclonal / HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors | |
Trastuzumab deruxtecan | Not Available | An antibody used to treat certain types of unresectable or metastatic HER2 positive breast cancer. | HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors | |
Trastuzumab emtansine | Not Available | An antineoplastic agent and antibody-drug conjugate used to treat HER2-overexpressing breast cancer. | Antibodies, Monoclonal / HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors | |
Tremelimumab | 149000.0 C6500H9974N1726O2026S52 | An anti-CTLA-4 antibody used to treat unresectable hepatocellular carcinoma in combination with durvalumab. | Antineoplastic Agents | |
Tuberculin purified protein derivative | Not Available | A purified protein used in the Mantoux test for Mycobacterium tuberculosis testing. | Antigens, Bacterial / Indicators and Reagents / Skin Test Antigen / Tuberculin / Tuberculosis Skin Test | |
Turoctocog alfa | 166000.0 C7480H11379N1999O2194S68 | An antihemorrhagic agent used for the treatment and prophylaxis of bleeding in patients of all ages with haemophilia A (congenital factor VIII deficiency). | Recombinant Proteins | |
Turoctocog alfa pegol | Not Available | Turoctocog alfa pegol is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to... | Amino Acids, Peptides, and Proteins / Biological Factors / Blood Coagulation Factors / Blood Proteins / Factor VIII / Hemostatics / Proteins / Recombinant Proteins | |
Ublituximab | 147000.0 | A low-fucose CD20-targeted monoclonal antibody used in the treatment of relapsing forms of multiple sclerosis. | Selective Immunosuppressants | |
Urofollitropin | 980.162 C42H65N11O12S2 | A form of purified human follicle stimulating hormone used to treat infertility in females by inducing follicle development in women without primary ovarian failure. | Gonadotropins | |
Urokinase | 31126.5 C1376H2145N383O406S18 | A low molecular weight form of human urokinase used to treat pulmonary embolism and myocardial infarction as well as to clear IV lines. | Enzymes | |
Ustekinumab | 148600.0 | A targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. | Interleukin Inhibitors | |
Vedolizumab | 146837.0 C6528H10072N1732O2042S42 | An integrin blocker and anti-inflammatory agent used to manage ulcerative colitis and Crohn's disease in adults. | Selective Immunosuppressants |
Displaying drugs 376 - 400 of 406 in total